News of the WeekAIDS VACCINE RESEARCH

Thumbs Down on Expensive, Hotly Debated Trial of NIH AIDS Vaccine

See allHide authors and affiliations

Science  25 Jul 2008:
Vol. 321, Issue 5888, pp. 472
DOI: 10.1126/science.321.5888.472

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

When he scuttled plans for a $63 million AIDS vaccine efficacy trial last week, Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, challenged researchers to come up with a "lean and mean" alternative.